Search Results 981-990 of 17093 for monoclonal antibody

1. Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52) - Mayo Clinic

   Prior anti-cancer monoclonal antibody (mAb) for direct anti-neoplastic treatment within 4 weeks prior to study Day 1 or who has not recovered from adverse ...

2. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

   Bezlotoxumab (CDI monoclonal antibodies) if received within the last year. Disease symptoms (e.g., diarrhea) caused by a confirmed intestinal pathogen other ...

3. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   ... monoclonal antibodies. Has evidence of ongoing uncontrolled systemic bacterial, fungal, or viral infection. Note: Subjects with localized fungal infections ...

4. Interpreting the News: COVID-19 Experimental Vaccines

   What is the significance of the BNT162b2 vaccine reportedly causing both antibodies and T cells to be made by the host? The immune system has two arms: humoral ...

5. Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) - Mayo Clinic

   deoxyribonucleic acid antibody seropositivity or anti-citrullinated protein antibodies-positive rheumatoid arthritis, or SSc mimics (eg, scleromyxedema,

6. A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 - Mayo Clinic

   Participation eligibility · Subjects with any history of hypersensitivity to any monoclonal antibody (including mepolizumab). · Subjects with current malignancy ...

7. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

   History of severe allergic or anaphylactic reactions to human, humanized or murine monoclonal antibodies. ... antibody-forming cells and of T cells into effector ...

8. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

   Known severe allergic reactions to TCZ or other monoclonal antibodies;; Active TB infection;; Suspected active bacterial, fungal, viral, or other infection ...

9. A Study to Evaluate Effectiveness and Quality of Life Outcomes of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Patients with history of prior daratumumab or another anti-CD38 monoclonal antibody treatment who were not refractory or intolerant to such therapy will be able ...

10. Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors - Mayo Clinic

    Monoclonal antibodies =< 3 half-lives prior to registration; Radiation therapy. Last fraction of craniospinal irradiation or total body irradiation =< 3 ...